Urinary Stent Development and Evaluation Models: In Vitro, Ex Vivo and In Vivo-A European Network of Multidisciplinary Research to Improve Urinary Stents (ENIUS) Initiative

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Buchholz, Noor
- de la Cruz, Julia
- Kram, Wolfgang
- Humphreys, Owen
- Reches, Meital
- Valero Boix, Raquel
- Soria, Federico
Grupos
Abstract
Background: When trying to modify urinary stents, certain pre-clinical steps have to be followed before clinical evaluation in humans. Usually, the process starts as an in silico assessment. The urinary tract is a highly complex, dynamic and variable environment, which makes a computer simulation closely reflecting physiological conditions extremely challenging. Therefore, the pre-clinical evaluation needs to go through further steps of in vitro, ex vivo and in vivo assessments. Methods and materials: Within the European Network of Multidisciplinary Research to Improve Urinary Stents (ENIUS), the authors summarized and evaluated stent assessment models in silico, in vitro, ex vivo and in vivo. The topic and relevant sub-topics were researched in a systematic literature search in Embase, Scope, Web of Science and PubMed. Clinicaltrials.gov was consulted for ongoing trials. Articles were selected systematically according to guidelines with non-relevant, non-complete, and non-English or Spanish language articles excluded. Results: In the first part of this paper, we critically evaluate in vitro stent assessment models used over the last five decades, outlining briefly their strengths and weaknesses. In the second part, we provide a step-by-step guide on what to consider when setting up an ex vivo model for stent evaluation on the example of a biodegradable stent. Lastly, the third part lists and discusses the pros and cons of available animal models for urinary stent evaluation, this being the final step before human trials. Conclusions: We hope that this overview can provide a practical guide and a critical discussion of the experimental pre-clinical evaluation steps needed, which will help interested readers in choosing the right methodology from the start of a stent evaluation process once an in silico assessment has been completed. Only a transparent multidisciplinary approach using the correct methodology will lead to a successful clinical implementation of any new or modified stent.
Datos de la publicación
- ISSN/ISSNe:
- 2073-4360, 2073-4360
- Tipo:
- Article
- Páginas:
- -
- Factor de Impacto:
- 0,726 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Polymers MDPI Open Access Publishing
Citas Recibidas en Web of Science: 4
Documentos
- No hay documentos
Filiaciones
Keywords
- animal models; design; encrustation; evaluation; ex vivo; in vitro; in vivo; material; urinary stent; urinary tract models
Proyectos asociados
ENSAYO MULTICÉNTRICO, CONTROLADO Y ALEATORIZADO PARA EVALUAR EL USO COMBINADO DE UN DISPOSITIVO MÉDICO Y UN COMPLEMENTO ALIMENTICIO EN EL CONTROL DEL PH URINARIO DE PACIENTES CON UN CATÉTER DOBLE J IMPLANTADO.
Investigador Principal: ALBERTO BUDÍA ALBA
DEV-LCD-02-17 . 2017
ESTUDIO ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO SOBRE LA ADICION DE DETROL LA A UN ALFABLOQUEANTE EN VARONES CON SINTOMAS PERSISTENTES DE VEJIGA HIPERACTIVA CONSISTENTES EN FRECUENCIA URINARIA Y URGENCIA CON O SIN INCONTINENCIA DE URGENCIA TRAS RECIBIR MONOTERAPIA PREVIA CON ALFABLOQUEANTE.
Investigador Principal: JUAN FERNANDO JIMENEZ CRUZ
A6121127
ESTUDIO ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE TAMSULOSINA OCAS (SISTEMA DE ABSORCION ORAL CONTROLADA) EN COMPRIMIDOS DE 0,4 Y 0,8 MG UNA VEZ AL DIA, TAMSULOSINAEN CAPSULAS DE LIBERACION MODIFICADA DE 0,4 MG (OMNIC) UNA VEZ AL DIA Y PLACEBO, EN PACIENTES CON SINTOMAS DE TRACTO URINARIO INFERIOR (STUI) SUGESTIVOS DE OBSTRUCCION PROSTATICA BENIGNA (OPB), ANTERIORMENTE DENOMINADA HIPERPLASIA BENIGNA DE PROSTATA (HBP) SINTOMATICA.
Investigador Principal: JUAN FERNANDO JIMENEZ CRUZ
02-OMN-02
ESTUDIO ALEATORIZADO DOBLE CIEGO Y CON GRUPOS PARALELOS PARA INVESTIGAR LA EFICACIA Y LA SEGURIDAD DEL TRATAMIENTO CON DUTASTERIDA (0,5MG) Y TAMSULOSINA (0,4MG) ADMINISTRADAS UNA VEZ AL DIA DURANTE 4 AÑOS, SOLAS O EN COMBINACION EN LA MEJORIA DE LOS SINTOMAS Y DEL RESULTADO CLINICO EN VARONES CON HIPERPLASIA BENIGNA DE PROSTATA SINTOMATICA MODERADA O GRAVE.
Investigador Principal: JUAN FERNANDO JIMENEZ CRUZ
ARI40005
ESTUDIO PARA EVALUAR LA CALIDAD DE VIDA Y SATISFACCION DEL TRATAMIENTO CON VARDENAFILO EN PACIENTES CON DISFUNCION ERECTIL Y COMORBILIDADES ASOCIADAS EN LA PRACTICA CLINICA HABITUAL (ESTUDIO REPEAT).
Investigador Principal: ALBERTO BUDÍA ALBA
BAY-VAR-2007-01_CANCELADO
ESTUDIO EXPERIMENTAL DE LA ADMINISTRACIÓN DE UN COMPLEMENTO ALIMENTICIO QUE CONTIENE ÁCIDO HIDROXICÍTRICO FRENTE A PLACEBO EN PACIENTES CON LITIASIS DE OXALATO Y DE FOSFATO CÁLCICO EN LOS QUE ESTÁ INDICADA LA LITOTRICIA EXTRACORPÓREA POR ONDAS DE CHOQUE.
Investigador Principal: ALBERTO BUDÍA ALBA
ARA-EXP/FAG-2019-03 . 2021
Cita
Buchholz N,Budia A,de la Cruz J,Kram W,Humphreys O,Reches M,Valero R,Soria F. Urinary Stent Development and Evaluation Models: In Vitro, Ex Vivo and In Vivo-A European Network of Multidisciplinary Research to Improve Urinary Stents (ENIUS) Initiative. Polymers (Basel). 2022. 14. (9):1641. IF:5,000. (1).